What Is BPC-157? A Complete Research Overview
Category: Research Guides • Reading time: ~7 minutes
BPC-157 is one of the most widely studied synthetic peptides in preclinical research. Originally derived from a protein naturally found in gastric juice, it has attracted significant scientific attention for its potential effects on tissue repair, inflammation, and vascular biology. If you’re new to BPC-157 research or looking to understand the science behind it, this guide covers everything you need to know.
BPC-157 is sold for research purposes only and is not approved for human use. All information below relates to preclinical research findings in animal models.
What Is BPC-157?
BPC-157 stands for Body Protection Compound 157. It is a 15-amino-acid synthetic peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a portion of a protein called BPC — a cytoprotective protein found in human gastric juice. The parent protein was first identified by researchers studying the protective mechanisms of the gastric mucosa.
The synthetic version (BPC-157) was isolated and studied specifically because the full-length BPC protein was found to contain a sequence with particularly interesting biological activity in preclinical models. Unlike many peptides that occur naturally in the body, BPC-157 in its research form is entirely synthetic — it does not exist in this exact form in nature.
Structural Properties
BPC-157 is a 15-amino-acid peptide with a molecular weight of approximately 1,419 Da. It is highly stable under acidic conditions — which is notable given its gastric origin — and resists degradation in biological fluids better than many peptides of similar size. In research settings, it is supplied as a lyophilised powder and reconstituted with bacteriostatic water prior to use.
How Is BPC-157 Studied to Work?
BPC-157’s mechanisms of action remain an active area of investigation. Preclinical studies have proposed several pathways through which it appears to exert its effects:
Angiogenesis and Vascular Biology
One of the most replicated findings in BPC-157 preclinical research is its apparent ability to stimulate angiogenesis — the formation of new blood vessels. Studies have shown upregulation of VEGF (vascular endothelial growth factor) expression in tissues treated with BPC-157. Since adequate blood supply is fundamental to tissue healing, this is considered a key mechanism underlying its observed effects on wound and injury recovery in animal models.
Growth Factor Modulation
BPC-157 appears to interact with several growth factor signalling pathways, including those mediated by EGF (epidermal growth factor) and HGF (hepatocyte growth factor). These interactions are thought to contribute to its observed effects on mucosal integrity, muscle and tendon repair, and fibroblast proliferation in preclinical studies.
Nitric Oxide System
Research has also implicated the nitric oxide (NO) system in BPC-157’s activity. Some studies suggest it can modulate NO production in both a stimulatory and inhibitory manner depending on the experimental context — a duality that may account for its reported effects in both inflammatory and protective settings.
FAK and Src Signalling
A 2021 study published in the journal Biomedicines proposed that BPC-157 activates the FAK-paxillin and Src signalling pathways, which regulate cell migration, adhesion, and proliferation. This mechanistic work is helping to explain the cellular basis of effects observed in earlier in vivo research.
Key Areas of Preclinical Research
BPC-157 has been investigated across a wide range of tissue types and biological systems. Here are the main areas where research has been conducted:
Research Area
Key Preclinical Findings
Musculoskeletal Repair
Accelerated tendon-to-bone healing and ligament repair in rodent models. Studies showed increased collagen fibre organisation and tensile strength.
Muscle Injury
Reduced recovery time and improved functional outcomes in models of crush injury and transection. Myofibre regeneration was enhanced compared to controls.
Gut and Mucosal Health
Significant protective effects in models of intestinal anastomosis, inflammatory bowel disease, and gastric ulceration. Mucosal integrity was preserved under experimental stress.
Joint and Cartilage
Studies in arthritic and surgically damaged joint models showed reduction in degeneration markers and improved functional scores.
Neurological Models
Explored in models of traumatic brain injury and spinal cord damage. Neurological recovery metrics were improved in several rodent studies.
Systemic Cytoprotection
The original gastric protein (BPC) was studied for broad cytoprotective properties. BPC-157 appears to retain some of this activity across multiple organ systems.
BPC-157 vs TB-500: How Do They Compare?
BPC-157 is frequently studied alongside TB-500 (Thymosin Beta-4 fragment), another research peptide studied for tissue repair. While both are investigated in recovery contexts, they have different mechanisms and tissue targets:
- BPC-157 is primarily associated with gut, tendon, and vascular biology. It acts locally and systemically and has strong preclinical data in gastrointestinal models.
- TB-500 works mainly via actin regulation and cell migration, with effects studied particularly in muscle, skin, heart, and eye tissue.
- Some researchers use both compounds in parallel or combination protocols, studying potential complementary effects.
Read our full comparison: BPC-157 vs TB-500.
Handling and Storage
BPC-157 is supplied as lyophilised (freeze-dried) white powder. For research use:
- Store lyophilised powder at -20°C in a sealed vial away from light and moisture
- Reconstitute with bacteriostatic water — inject water gently down the side of the vial, do not shake
- Once reconstituted, store at 4°C and use within 30 days
- Avoid repeated freeze-thaw cycles
Full reconstitution instructions: How to Reconstitute Peptides.
Research Grade BPC-157
All BPC-157 supplied by Peptide Research Store is manufactured to research-grade specifications:
- Purity ≥98% verified by HPLC
- Identity confirmed by mass spectrometry (MS)
- Certificate of Analysis (CoA) included with every batch
- Lyophilised format for maximum shelf stability
View BPC-157 Product Page →
Also available: BPC-157 + TB-500 Blend.
⚠️ Research Use Disclaimer
All peptides sold by Peptide Research Store are intended strictly for in vitro research and laboratory use only. They are not intended for human or veterinary use, consumption, or therapeutic application of any kind. These products have not been evaluated by Health Canada or the FDA for safety or efficacy in humans. By purchasing, you confirm you are a qualified researcher using products in accordance with all applicable laws.
Reviewed by the Peptide Research Store editorial team • Last updated: March 2026 • Sources: PubMed / NCBI